ID   RIP3_MOMCH              Reviewed;         286 AA.
AC   P24817; Q41257; Q9FSH2; Q9FUV7;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 2.
DT   07-APR-2021, entry version 98.
DE   RecName: Full=Ribosome-inactivating protein beta-momorcharin;
DE            Short=B-MMC;
DE            EC=3.2.2.22;
DE   AltName: Full=MAP 30;
DE   AltName: Full=rRNA N-glycosidase;
DE   Flags: Precursor;
GN   Name=MAP30; Synonyms=RIP;
OS   Momordica charantia (Bitter gourd) (Balsam pear).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Cucurbitales; Cucurbitaceae; Momordiceae; Momordica.
OX   NCBI_TaxID=3673;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Leaf;
RX   PubMed=7665070; DOI=10.1016/0378-1119(95)00186-a;
RA   Lee-Huang S., Huang P.L., Chen H.-C., Huang P.L., Bourinbaiar A.,
RA   Huang H.I., Kung H.-F.;
RT   "Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter
RT   melon.";
RL   Gene 161:151-156(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RA   Quanhong Y., Rihe P., Aisheng X.;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 23-286.
RA   Wei Y.-F., Cai L.-B., Zhuang W.;
RT   "Cloning rip gene and identification of its resistance to Aspergillus
RT   flavus.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 23-286.
RA   Nguyen Huy H., Nghiem Ngoc M., Dao Huy P., Le Tran B., Nong Van H.;
RT   "Expression of a RIP gene from Momordica charantia in E. coli.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 24-67.
RC   TISSUE=Seed;
RX   PubMed=1699801; DOI=10.1016/0014-5793(90)80438-o;
RA   Lee-Huang S., Huang P.L., Nara P.L., Chen H.-C., Kung H.-F., Huang P.,
RA   Huang H.I., Huang P.L.;
RT   "MAP 30: a new inhibitor of HIV-1 infection and replication.";
RL   FEBS Lett. 272:12-18(1990).
RN   [6]
RP   STRUCTURE BY NMR OF 24-286, AND DNA-BINDING.
RX   PubMed=10571185; DOI=10.1016/s0092-8674(00)81529-9;
RA   Wang Y.-X., Neamati N., Jacob J., Palmer I., Stahl S.J., Kaufman J.D.,
RA   Huang P.L., Huang P.L., Winslow H.E., Pommier Y., Wingfield P.T.,
RA   Lee-Huang S., Bax A., Torchia D.A.;
RT   "Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural
RT   insights into its multiple functions.";
RL   Cell 99:433-442(1999).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 24-272.
RX   PubMed=10329776; DOI=10.1107/s0907444999003297;
RA   Yuan Y.-R., He Y.-N., Xiong J.-P., Xia Z.-X.;
RT   "Three-dimensional structure of beta-momorcharin at 2.55 A resolution.";
RL   Acta Crystallogr. D 55:1144-1151(1999).
CC   -!- FUNCTION: Irreversibly relaxes supercoiled DNA and catalyzes double-
CC       stranded breakage. Acts also as a ribosome inactivating protein.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endohydrolysis of the N-glycosidic bond at one specific
CC         adenosine on the 28S rRNA.; EC=3.2.2.22;
CC   -!- PTM: Bound to a branched hexasaccharide.
CC   -!- MISCELLANEOUS: Possesses anti-HIV and antitumoral activities. Inhibits
CC       HIV-1 integrase.
CC   -!- MISCELLANEOUS: Manganese or zinc required for enhancing substrate
CC       binding rather than catalysis.
CC   -!- MISCELLANEOUS: The oligosaccharide does not influence the fold of the
CC       polypeptide chain and probably does not play a role in the enzymatic
CC       function.
CC   -!- MISCELLANEOUS: Is not toxic to uninfected normal cells as it cannot
CC       enter into them.
CC   -!- SIMILARITY: Belongs to the ribosome-inactivating protein family. Type 1
CC       RIP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S79450; AAB35194.2; -; Genomic_DNA.
DR   EMBL; AF284811; AAG33028.1; -; Genomic_DNA.
DR   EMBL; AY523412; AAS17014.1; -; mRNA.
DR   EMBL; AJ294541; CAC08217.1; -; Genomic_DNA.
DR   PIR; B61318; B61318.
DR   PIR; JC4235; JC4235.
DR   PDB; 1CF5; X-ray; 2.55 A; A/B=24-272.
DR   PDB; 1D8V; NMR; -; A=24-286.
DR   PDBsum; 1CF5; -.
DR   PDBsum; 1D8V; -.
DR   BMRB; P24817; -.
DR   SMR; P24817; -.
DR   BRENDA; 3.2.2.22; 3398.
DR   EvolutionaryTrace; P24817; -.
DR   Proteomes; UP000504603; Genome assembly.
DR   GO; GO:0030598; F:rRNA N-glycosylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006952; P:defense response; IEA:UniProtKB-KW.
DR   GO; GO:0017148; P:negative regulation of translation; IEA:UniProtKB-KW.
DR   GO; GO:0050688; P:regulation of defense response to virus; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.420.10; -; 1.
DR   Gene3D; 4.10.470.10; -; 1.
DR   InterPro; IPR036041; Ribosome-inact_prot_sf.
DR   InterPro; IPR017989; Ribosome_inactivat_1/2.
DR   InterPro; IPR001574; Ribosome_inactivat_prot.
DR   InterPro; IPR017988; Ribosome_inactivat_prot_CS.
DR   InterPro; IPR016138; Ribosome_inactivat_prot_sub1.
DR   InterPro; IPR016139; Ribosome_inactivat_prot_sub2.
DR   PANTHER; PTHR33453; PTHR33453; 1.
DR   Pfam; PF00161; RIP; 1.
DR   PRINTS; PR00396; SHIGARICIN.
DR   SUPFAM; SSF56371; SSF56371; 1.
DR   PROSITE; PS00275; SHIGA_RICIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral protein; Direct protein sequencing; Glycoprotein;
KW   Hydrolase; Plant defense; Protein synthesis inhibitor; Reference proteome;
KW   Signal; Toxin.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:1699801"
FT   CHAIN           24..286
FT                   /note="Ribosome-inactivating protein beta-momorcharin"
FT                   /id="PRO_0000030773"
FT   ACT_SITE        93
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        132
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        181
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        184
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   CONFLICT        23
FT                   /note="G -> M (in Ref. 3 and 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        37
FT                   /note="Y -> T (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67
FT                   /note="S -> P (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        147
FT                   /note="D -> E (in Ref. 4; CAC08217)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        188
FT                   /note="I -> T (in Ref. 1; AAB35194)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="G -> A (in Ref. 4; CAC08217)"
FT                   /evidence="ECO:0000305"
FT   STRAND          25..28
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           29..31
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           34..45
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          50..54
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          57..60
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          68..76
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          82..88
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   TURN            89..91
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          94..99
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          102..106
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           111..116
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          121..128
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           132..139
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           143..145
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           150..161
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   TURN            165..167
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           168..177
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           180..184
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           186..194
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          196..200
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           205..210
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   TURN            211..214
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           215..222
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   TURN            223..228
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          229..237
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   TURN            239..241
FT                   /evidence="ECO:0007744|PDB:1D8V"
FT   STRAND          243..248
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   HELIX           252..256
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   STRAND          260..262
FT                   /evidence="ECO:0007744|PDB:1D8V"
FT   HELIX           264..269
FT                   /evidence="ECO:0007744|PDB:1CF5"
FT   TURN            274..276
FT                   /evidence="ECO:0007744|PDB:1D8V"
FT   TURN            279..281
FT                   /evidence="ECO:0007744|PDB:1D8V"
SQ   SEQUENCE   286 AA;  32031 MW;  6B2DF55A41D8F921 CRC64;
     MVKCLLLSFL IIAIFIGVPT AKGDVNFDLS TATAKTYTKF IEDFRATLPF SHKVYDIPLL
     YSTISDSRRF ILLNLTSYAY ETISVAIDVT NVYVVAYRTR DVSYFFKESP PEAYNILFKG
     TRKITLPYTG NYENLQTAAH KIRENIDLGL PALSSAITTL FYYNAQSAPS ALLVLIQTTA
     EAARFKYIER HVAKYVATNF KPNLAIISLE NQWSALSKQI FLAQNQGGKF RNPVDLIKPT
     GERFQVTNVD SDVVKGNIKL LLNSRASTAD ENFITTMTLL GESVVN
//
